Pharmanutra
Develops and distributes nutritional supplements and medical devices based on research.
PHN | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005274094
- LEI:
- 815600F8217BC7733697
- Country:
- Italy
- Address:
- VIA CAMPODAVELA, 1, 56122 PISA
- Website:
- http://www.pharmanutra.it
- Sector:
- Manufacturing
Description
PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-24 17:00 |
PHN Explanatory Memorandum on buy back
|
English | 350.0 KB | ||
| 2025-03-24 16:59 |
PHN Relazione illustrativa azioni proprie
|
Italian | 426.5 KB | ||
| 2025-03-24 16:58 |
CS disponibilità relazioni illustrative || PR Notice of availability
|
Italian | 179.5 KB | ||
| 2025-03-24 07:30 |
Pharmanutra: Ferro sucrosomiale menzionato nelle linee guida WHO
|
Italian | 160.0 KB | ||
| 2025-03-24 07:30 |
PHN Sucrosomial Iron mentioned in guidance WHO
|
English | 235.8 KB | ||
| 2025-03-23 07:20 |
NOTICE OF FILING OF THE LIST FOR THE APPOINTMENT OF THE BOARD OF STATUTORY AUDI…
|
English | 215.6 KB | ||
| 2025-03-23 07:20 |
AVVISO DI DEPOSITO DELLA LISTA PER LA NOMINA DEL COLLEGIO SINDACALE
|
Italian | 188.3 KB | ||
| 2025-03-19 09:25 |
EXPLANATORY MEMORANDUM on point 5 of the Shareholders Meeting
|
English | 457.7 KB | ||
| 2025-03-19 09:24 |
RELAZIONE ILLUSTRATIVA sul 5 punto all'ordine del giorno
|
Italian | 442.1 KB | ||
| 2025-03-19 09:23 |
Explanatory memorandum on remuneration report
|
English | 427.3 KB | ||
| 2025-03-19 09:22 |
Relazione Illustrativa sulla Relazione di Remunerazione
|
Italian | 440.9 KB | ||
| 2025-03-19 09:21 |
Explanatory memorandum on the financial statement 2024
|
English | 385.2 KB | ||
| 2025-03-19 09:20 |
Relazione Illustrativa al Bilancio 2024
|
Italian | 349.1 KB | ||
| 2025-03-17 13:28 |
Pharmanutra || PR clarification and integration note
|
English | 210.3 KB | ||
| 2025-03-17 13:26 |
Pharmanutra || CS ad integrazione e chiarimento
|
Italian | 170.0 KB |
Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharmanutra
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharmanutra via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
